Table 1.

Inclusion & Exclusion Criteria

Inclusion:

(1) Age ≥ 65 years;

(2) Presence of at least one chronic condition*;

(3) Ability to speak, read and understand English

Exclusion:

(1) ≤ 2 Mini-Cog score,

(2) Presence of active cancer treatment or terminal illness;

(3) Presence of degenerative neurological condition**;

(4) Use of specific anti-inflammatory drags including IL-6 inhibitors and TNF-α inhibitors***

^*Chronic conditions include: diabetes, arthritis, high cholesterol, hypertension or cerebrovascular, cardiovascular, renal, chronic lung or liver disease.

^**Degenerative neurological conditions including: Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Chorea, Guillain-Barre Syndrome, Amyotrophic Lateral Sclerosis

^***Drugs in this category include: infliximab (Remicade), adalimumab (Humira), certolizumab pegol (Cimzia), etanercept (Enbrel), tocilizumab (Actemra), atlizumab (RoActemra), sirukumab (Sylvant)